PIS
JAZZ icon

POM Investment Strategies’s Jazz Pharmaceuticals JAZZ Stock Holding History

POM Investment Strategies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29
Closed -$5.48K – 407
2026
Q1 		$5.48K Buy
+29
New +$5.07K 0.01% 255

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

POM Investment Strategies's JAZZ Position: Q2 2026 in Review

POM Investment Strategies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 29 shares — an estimated $5.48K sold.

POM Investment Strategies first reported a position in JAZZ in Q1 2026 and held it in 1 quarter. The position peaked at $5.48K in Q1 2026. 296 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • POM Investment Strategies reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • POM Investment Strategies sold 29 Jazz Pharmaceuticals shares in Q2 2026, an estimated $5.48K.
  • POM Investment Strategies first reported a position in Jazz Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • POM Investment Strategies's Jazz Pharmaceuticals position peaked at $5.48K in Q1 2026.
  • 296 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.